➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Medtronic
Colorcon
McKesson
Dow

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for NCR Corporation v. Documotion Research Inc. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in NCR Corporation v. Documotion Research Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in NCR Corporation v. Documotion Research Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for NCR Corporation v. Documotion Research Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2015-10-16 101 35 10:30:51 1 patent and you say what is going on here, what…'811 patent. 09:44:05 8 THE COURT: I think we have the patent, but we …And the patent examiner, in looking at that, 09:49:45 24 said, hey, you can't patent this …17 bit. In connection with another patent, another patent that 09:51:03 18 we are going…term of the '264 patent -- again, it is a different 09:51:34 25 patent -- Case External link to document
2015-04-30 59 2:5; 3:55 – 4:6; 5:20; 5:30-47; …patches of ’811 patent, ’811 patent, discrete adhesive patent, 1 meaning …adhesive is ’811 patent, ’811 patent, in a minor area of patent, 1 comprising …surface has ’811 patent, ’811 patent, remaining major patent, 1 that are free…and ordinary ’811 patent, ’811 patent, major area patent, 2 that are free External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
McKesson
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.